Navigation Links
Shamir Optical Industry Ltd. to Host Conference Call Announcing Fourth Quarter and Year End 2007 Earnings Results
Date:2/27/2008

KIBBUTZ SHAMIR, Israel, Feb. 27 /PRNewswire-FirstCall/ -- Shamir Optical Industry Ltd. (Nasdaq: SHMR) ("Shamir") expects to issue its fourth quarter and year end 2007 earnings results on Thursday, March 6, 2008, and has scheduled a conference call to discuss the results at 9:00 A.M. EST that morning.

The conference call will be broadcast live as a listen-only webcast. To listen live, please go to http://www.kcsa.com approximately five minutes before the conference call is scheduled to begin. You will need to register, and may need to download and install the required audio software. The webcast will be archived for 30 days following the call.

About Shamir

Shamir is a leading provider of innovative products and technology to the progressive spectacle lens market. Utilizing its proprietary technology, the company develops, designs, manufactures, and markets progressive lenses to sell to the ophthalmic market. In addition, Shamir utilizes its technology to provide design services to optical lens manufacturers under service and royalty agreements. Progressive lenses are used to treat presbyopia, a vision condition where the eye loses its ability to focus on close objects. Progressive lenses combine several optical strengths into a single lens to provide a gradual and seamless transition from near to intermediate, to distant vision. Shamir differentiates its products from its competitors' primarily through lens design. Shamir's leading lenses are marketed under a variety of trade names, including Shamir Genesis(TM), Shamir Piccolo(TM), Shamir Office(TM), and Shamir Autograph(TM). Shamir believes that it has one of the world's preeminent research and development teams for prog
'/>"/>

SOURCE Shamir Optical Industry Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Shamir Optical Industry Ltd. to Host Conference Call Announcing Third Quarter 2007 Earnings Results
2. Optical scientist honored for understanding and improving vision
3. Minority patients prefer optical colonoscopy for colorectal cancer screening
4. Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform
5. Optical Coherence Tomography Market to Top $800 Million by 2012
6. Transitions Optical Promotes Healthy Sight Through a Nationwide Integrated Advertising Campaign and the Launch of an Enhanced Consumer Web Site
7. Optical frequency comb can detect the breath of disease
8. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
9. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
10. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
11. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... A new website providing su...lung cancer has been launched at TheFaceofLungCanc...and survivors while distilling important informati... (PRWEB) November 9, 2009 ... public square, and in recognition of November&rsq...
(Date:11/9/2009)... Omnetics Connector Corpora...A systems have been certified. , ...- Omnetics Connector Corporation, the leading manu...ed that their design, production and QA systems ha...& AS9100 Revision B, International Quality System ...
(Date:11/9/2009)..., SAN DIEGO, Nov. 9 HUYA Biosc...,s biopharmaceutical innovation, today announced a... and Pharmacy, Ocean University of China. The agre...t HUYA has established with China,s leading resear...lerate the global development and commercializatio...
(Date:11/9/2009)...A new study finds that women treated for breast ca...ey have dense breasts. Published in the December 1... of the American Cancer Society, the study,s resul... breasts may benefit from additional therapies fol...udies indicate that women with dense breast tissue...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 ...sued the following statement about the passage of ... and the American voters a lot about core values. ...ore values, seeking to overcome the struggles ordi...les mean that many cannot afford basic healthcare ...
Breaking Medicine News(10 mins):Health News:The Face of Lung Cancer Support and Information Website Launches to Increase Awareness and Advocacy 2Health News:The Face of Lung Cancer Support and Information Website Launches to Increase Awareness and Advocacy 3Health News:Omnetics Connector Corporation Achieves AS9100 Certification 2Health News:HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China 2Health News:Breast density associated with increased risk of cancer recurrence 2Health News:Catholics for Choice Statement on Healthcare Reform Bill 2
... CINCINNATIOften, a gentle hand on your shoulder ...d and calm your nerves. , Now, University of Cinc...ccurrence by pairing a complementary therapy known...ques that balance energy for wholeness within a pe...
...ASHINGTON, July 1 Beginning July 6, Sharing,Mirac...am that tells the,compelling and inspirational sto...ympic Gold Medal-winner Greg Louganis. Also on Jul...r Greg Louganis won the hearts of sports fans worl...
... Virginia Commonwealth University and VCU Massey ...e, melanoma differentiation associated gene-7/inte...ct that kills cancer cells not directly receiving ...provide a method to target metastatic disease whi...
...TLANTA, July 1 Children,s Healthcare of Atlanta a...ey are joining forces in the,fight against autism....iary, Marcus Autism Center, which will offer servi...ns who are already serving,the needs of children w...
...USTIN, Texas, July 1 Opus Healthcare Solutions, I...ation systems, has named Ray,Bechtold, CPA, as con...s,Bechtold will be responsible for overseeing all ...cgi-bin/prnh/20080325/LATU040LOGO ), Bechtold joi...
... Providence, RI What began as a college course pr...he first toys of their kind, designed as therapy f...disorder that affects the development of the brain...proving function, however, Karen Kerman, M.D., dir...
Other Medicine News:Health News:Effects of healing touch therapy being studied 2Health News:'Sharing Miracles' Television Program to Feature Olympic Gold Medal-Winner Greg Louganis 2Health News:'Sharing Miracles' Television Program to Feature Olympic Gold Medal-Winner Greg Louganis 3Health News:'Sharing Miracles' Television Program to Feature Olympic Gold Medal-Winner Greg Louganis 4Health News:'Sharing Miracles' Television Program to Feature Olympic Gold Medal-Winner Greg Louganis 5Health News:'Sharing Miracles' Television Program to Feature Olympic Gold Medal-Winner Greg Louganis 6Health News:Discovery of gene mechanism could bring about new ways to treat metastatic cancer 2Health News:Children's Healthcare of Atlanta to Open Marcus Autism Center 2Health News:Opus Healthcare Solutions Names Ray Bechtold as Controller 2Health News:Toys and technology for rehabilitation in cerebral palsy patients 2Health News:Toys and technology for rehabilitation in cerebral palsy patients 3
(Date:11/6/2009)... 6 Boston Scientific Cor... reached an agreement in principle with the U.S. D...sories issued by its Guidant subsidiary in 2005. ...or to Boston Scientific,s 2006 acquisition of Guid...sed an investigation by the U.S. Attorney,s Office...
(Date:11/6/2009)...RNewswire-FirstCall/ -- Keryx Biopharmaceuticals, ...on Tuesday, November 10, 2009 at 8:30 a.m. EST to ...nd business outlook for the remainder of 2009. Ro... will host the call. Keryx will announce its fina...o be issued prior to the call. ,, In order to p...
(Date:11/6/2009)...Newswire-FirstCall/ -- Caraco Pharmaceutical Labor...rolac tromethamine ophthalmic solution, 0.5% follo...ministration (FDA) for Sun Pharma,s Abbreviated Ne... opthalmic solution on the first day following pat...apeutically equivalent to Acular® Ophthalmic ...
Breaking Medicine Technology:Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 1Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 2Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 3Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 4Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 5Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 6Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 7Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 8UC San Diego researchers reverse pulmonary arterial hypertension in mouse models 60038 1UC San Diego researchers reverse pulmonary arterial hypertension in mouse models 60038 2CSHL led team discovers rare mutation dramatically increasing schizophrenia risk 10513 1CSHL led team discovers rare mutation dramatically increasing schizophrenia risk 10513 2
...mistry analysis, often conducted in a physicians o...on of a wide array of ailments; UTIs, diabetes, se... and kidney diseases. The estimated global market...llion per year and is growing strongly. For such a...nt clinical procedure, the manufacturers of urinal...
...amonte Content Editor Medcompare.com ,Accor...UNAIDS (Joint United Nations Programme on HIV/AIDS... people living with HIV globally reached an estima... 3 million deaths caused by AIDS. The latest data...ver one million people in the United States are no...
Other Medicine Technology:Urinalysis Analyzers: Large Capabilities in Every Size Device 2Urinalysis Analyzers: Large Capabilities in Every Size Device 3Rapid HIV Testing Increases Possibility of Treatment 2Rapid HIV Testing Increases Possibility of Treatment 3
Micro Decker Rongeur
Thin Footplate Kerrison Rongeurs
Synovectomy Rongeur
Husk Rongeurs
Medicine Products: